Home / Health / Abbott Launches Tool to Fight Diabetes Heart & Kidney Risks in India
Abbott Launches Tool to Fight Diabetes Heart & Kidney Risks in India
12 Mar
Summary
- Abbott introduced the ICRAS tool to help doctors identify heart and kidney risks.
- India has 101 million people living with diabetes, facing common heart/kidney complications.
- The web-based tool assesses risks for heart disease, kidney disease, and major cardiac events.
Abbott has unveiled the International Cardio‑Renal Risk Assessment and Stratification (ICRAS) Tool, a new web-based resource for clinicians in India. This tool is designed to assist doctors in identifying potential heart and kidney risks among individuals diagnosed with Type 2 Diabetes Mellitus (T2DM).
India, known as the 'diabetes capital of the world,' has approximately 101 million people living with diabetes. Heart and kidney conditions are frequent and severe complications of T2DM, making early risk assessment vital. The ICRAS Tool aids in the early stratification of cardio‑renal risk, aiming to enhance health outcomes and mitigate T2DM-related complications.
The tool analyzes key health indicators, including medical test results and lifestyle factors, to generate specific risk scores for kidney disease, heart disease, and major adverse cardiovascular events. It also accounts for gender-based risk differences, providing a personalized risk summary for each patient.
Developed with expert guidance, the ICRAS Tool ensures privacy as it does not collect any personal patient or doctor information. This initiative underscores Abbott's commitment to improving diabetes care delivery and patient outcomes through advanced screening and decision-making support.
